Editas Medicine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). 

CEO
Gilmore O’Neill
CEOGilmore O’Neill
Employees
246
Employees246
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
246
Employees246

EDIT Key Statistics

Market cap
138.13M
Market cap138.13M
Price-Earnings ratio
-0.54
Price-Earnings ratio-0.54
Dividend yield
Dividend yield
Average volume
2.06M
Average volume2.06M
High today
$1.67
High today$1.67
Low today
$1.44
Low today$1.44
Open price
$1.49
Open price$1.49
Volume
2.38M
Volume2.38M
52 Week high
$6.22
52 Week high$6.22
52 Week low
$0.9101
52 Week low$0.9101

EDIT News

TipRanks 7d
Editas Medicine Unveils Promising Gene Editing Data

Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...

Analyst ratings

50%

of 16 ratings
Buy
37.5%
Hold
50%
Sell
12.5%

People also own

Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.